Serum DPPIV activity and CD26 expression on lymphocytes in patients with benign or malignant breast tumors

Determination of the clinical outcome of analyzed patients, 1 and 2 years after the surgical resection of the tumor, would clarify potential prognostic values of examined parameters for breast cancer.